Drug Profile
Research programme: cannabinoid therapeutics - Cannabis Biosciences
Alternative Names: Phytocannabinoids - Cannabis Biosciences/Plandai Biotechnology; Phytofare® cannabinoid complex; Phytofare® cannabis extractsLatest Information Update: 28 Nov 2018
Price :
$50
*
At a glance
- Originator Cannabis Bioscience
- Class Cannabinoids
- Mechanism of Action Antioxidants; Cannabinoid receptor CB1 modulators; Cannabinoid receptor CB2 modulators; Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease; Amyotrophic lateral sclerosis; Brain injuries; Cancer; Multiple sclerosis; Parkinson's disease
Most Recent Events
- 28 Nov 2018 No recent reports of development identified for research development in Cancer in USA
- 28 Jul 2018 No recent reports of development identified for research development in Alzheimer's-disease in USA
- 28 Jul 2018 No recent reports of development identified for research development in Amyotrophic-lateral-sclerosis in USA